Annual Net Income
-$38.37 M
+$6.06 M+13.64%
December 31, 2023
Summary
- As of February 8, 2025, ITRM annual net profit is -$38.37 million, with the most recent change of +$6.06 million (+13.64%) on December 31, 2023.
- During the last 3 years, ITRM annual net income has risen by +$13.63 million (+26.22%).
- ITRM annual net income is now -184.99% below its all-time high of -$13.46 million, reached on December 31, 2016.
Performance
ITRM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$6.09 M
-$1.10 M-21.95%
September 30, 2024
Summary
- As of February 8, 2025, ITRM quarterly net profit is -$6.09 million, with the most recent change of -$1.10 million (-21.95%) on September 30, 2024.
- Over the past year, ITRM quarterly net income has stayed the same.
- ITRM quarterly net income is now -178.15% below its all-time high of $7.80 million, reached on June 30, 2021.
Performance
ITRM Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$30.55 M
-$2.22 M-7.82%
September 30, 2024
Summary
- As of February 8, 2025, ITRM TTM net profit is -$30.55 million, with the most recent change of -$2.22 million (-7.82%) on September 30, 2024.
- Over the past year, ITRM TTM net income has stayed the same.
- ITRM TTM net income is now -892.17% below its all-time high of $3.86 million, reached on March 31, 2022.
Performance
ITRM TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ITRM Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.6% | 0.0% | 0.0% |
| 3 y3 years | +26.2% | 0.0% | 0.0% |
| 5 y5 years | +50.2% | 0.0% | 0.0% |
ITRM Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +58.1% | -74.1% | +79.1% | -892.2% | +66.6% |
| 5 y | 5-year | at high | +62.8% | -178.2% | +93.8% | -892.2% | +77.3% |
| alltime | all time | -185.0% | +62.8% | -178.2% | +93.8% | -892.2% | +77.3% |
Iterum Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.09 M(+22.0%) | -$30.55 M(+7.8%) |
| Jun 2024 | - | -$5.00 M(-29.6%) | -$28.34 M(-20.4%) |
| Mar 2024 | - | -$7.10 M(-42.6%) | -$35.58 M(-7.3%) |
| Dec 2023 | -$38.37 M(-13.6%) | -$12.36 M(+218.9%) | -$38.37 M(+23.4%) |
| Sep 2023 | - | -$3.88 M(-68.3%) | -$31.10 M(-44.8%) |
| Jun 2023 | - | -$12.24 M(+23.8%) | -$56.33 M(+10.8%) |
| Mar 2023 | - | -$9.89 M(+94.3%) | -$50.82 M(+14.4%) |
| Dec 2022 | -$44.43 M(-51.5%) | -$5.09 M(-82.5%) | -$44.43 M(+2.1%) |
| Sep 2022 | - | -$29.11 M(+332.2%) | -$43.53 M(+307.7%) |
| Jun 2022 | - | -$6.74 M(+92.4%) | -$10.68 M(-376.8%) |
| Mar 2022 | - | -$3.50 M(-16.3%) | $3.86 M(-104.2%) |
| Dec 2021 | -$91.56 M(+76.1%) | -$4.18 M(-211.8%) | -$91.56 M(-7.1%) |
| Sep 2021 | - | $3.74 M(-52.0%) | -$98.57 M(-13.9%) |
| Jun 2021 | - | $7.80 M(-107.9%) | -$114.51 M(-15.1%) |
| Mar 2021 | - | -$98.92 M(+784.3%) | -$134.83 M(+159.3%) |
| Dec 2020 | -$52.01 M | -$11.19 M(-8.3%) | -$52.01 M(-19.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$12.20 M(-2.6%) | -$64.46 M(-22.8%) |
| Jun 2020 | - | -$12.52 M(-22.2%) | -$83.53 M(-15.3%) |
| Mar 2020 | - | -$16.10 M(-31.9%) | -$98.65 M(-4.3%) |
| Dec 2019 | -$103.13 M(+33.8%) | -$23.64 M(-24.4%) | -$103.13 M(-0.6%) |
| Sep 2019 | - | -$31.27 M(+13.1%) | -$103.75 M(+6.5%) |
| Jun 2019 | - | -$27.64 M(+34.3%) | -$97.38 M(+13.9%) |
| Mar 2019 | - | -$20.58 M(-15.2%) | -$85.49 M(+10.9%) |
| Dec 2018 | -$77.06 M(+162.0%) | -$24.26 M(-2.6%) | -$77.06 M(+24.5%) |
| Sep 2018 | - | -$24.91 M(+58.2%) | -$61.92 M(+37.0%) |
| Jun 2018 | - | -$15.75 M(+29.6%) | -$45.18 M(+26.5%) |
| Mar 2018 | - | -$12.15 M(+33.2%) | -$35.72 M(+21.5%) |
| Dec 2017 | -$29.41 M(+118.4%) | -$9.12 M(+11.6%) | -$29.41 M(+44.9%) |
| Sep 2017 | - | -$8.17 M(+30.1%) | -$20.29 M(+67.4%) |
| Jun 2017 | - | -$6.28 M(+7.6%) | -$12.12 M(+107.6%) |
| Mar 2017 | - | -$5.84 M | -$5.84 M |
| Dec 2016 | -$13.46 M | - | - |
FAQ
- What is Iterum Therapeutics annual net profit?
- What is the all time high annual net income for Iterum Therapeutics?
- What is Iterum Therapeutics annual net income year-on-year change?
- What is Iterum Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Iterum Therapeutics?
- What is Iterum Therapeutics quarterly net income year-on-year change?
- What is Iterum Therapeutics TTM net profit?
- What is the all time high TTM net income for Iterum Therapeutics?
- What is Iterum Therapeutics TTM net income year-on-year change?
What is Iterum Therapeutics annual net profit?
The current annual net income of ITRM is -$38.37 M
What is the all time high annual net income for Iterum Therapeutics?
Iterum Therapeutics all-time high annual net profit is -$13.46 M
What is Iterum Therapeutics annual net income year-on-year change?
Over the past year, ITRM annual net profit has changed by +$6.06 M (+13.64%)
What is Iterum Therapeutics quarterly net profit?
The current quarterly net income of ITRM is -$6.09 M
What is the all time high quarterly net income for Iterum Therapeutics?
Iterum Therapeutics all-time high quarterly net profit is $7.80 M
What is Iterum Therapeutics quarterly net income year-on-year change?
Over the past year, ITRM quarterly net profit has changed by $0.00 (0.00%)
What is Iterum Therapeutics TTM net profit?
The current TTM net income of ITRM is -$30.55 M
What is the all time high TTM net income for Iterum Therapeutics?
Iterum Therapeutics all-time high TTM net profit is $3.86 M
What is Iterum Therapeutics TTM net income year-on-year change?
Over the past year, ITRM TTM net profit has changed by $0.00 (0.00%)